PATENT CLAIM ANALYSIS

Application Number: 16059301
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "133100"]

Abstract:
Provided herein are materials and methods for delivering immunoglobulins (e.g. therapeutic immunoglobulins) across the blood-brain barrier.

Claim (Index 21):
The method of  claim 20 , wherein the linker is one or more hydrophilic amino acids.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15246232', '13229900', '16092671', '15579988', '16092680']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7682385538427338
- 35 USC 102 Novelty (BERT): 0.5748039825088165
- Combined Prediction Score: 0.7488950967093421
- Mean Citation Score: 383.311028
- Max Citation Score: 531.6647
- Similarity Product: 358.4260303393901

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test